This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...